Abstract Introduction: Lung cancer is the most common cause of cancer related death worldwide. Mostly these tumors present with cough, chest pain weight loss. However, presentation as breast mass and cardiac tamponade is very rare. Results: We are presenting a rare case of breast metastasis from primary lung cancer. This case presented as cardiac tamponade adding to the diagnostic dilemma. Conclusion: The importance of this case is to highlight molecular profiling as an applicable tool to distinguish extra-mammary metastasis that masquerade as mammary neoplasm thereby preventing unnecessary need of surgery and radiation therapy. 
Introduction
Lung cancer is the most common cause of death from cancer worldwide [1] . Metastatic dissemination of lung cancer occurs in 56% of cases at presentation commonly to contra-lateral lung, liver, bone, adrenals, brain, lymph nodes [2, 3] . We report a unique presentation of a lady with NSCLC with metachronous breast metastasis and cardiac tamponade emphasizing importance of IHC in differentiation of breast primary and breast metastasis.
Case report
A 30 year old female presented with complaints of persistent cough for 4 months. Evaluation with 2 samples of sputum for acid fast bacilli and chest radiograph was found normal. She was started on daily regimen of anti-tuberculosis therapy. After 2 months, she developed dyspnea grade 2 (New York Heart association classification). In our Institute, on evaluation, she was thin built with ECOG performance status 2, with no known co-morbidities and familial malignancies. Clinical 
Discussion
Primary breast carcinoma is the most common malignancy in women worldwide. Metastatic involvement of the breast is a rarity with a reported frequency of 0.4-1.3%. In a review of 14,000 breast cancer cases between 1907 and 1999, 0.43% was reported to be metastasis [4] . According to case reports and case series most common sources of metastasis to breast are hematological malignancies (leukemia, lymphomas) malignant melanoma, tumors of lung, kidney, ovary, thyroid, small bowel carcinoids, and colo-rectum [5] [6] [7] [8] .
Metastasis to breast may be lymphatic or hematogenous. Lymphatic may be due to initial pleural seeding with chest wall lymphatic involvement which drains to ipsilateral axillary lymph nodes and retrograde spread to lymphatic system of Tellate features on clinical examination, mammography, and ultra-sonogram of the breast may be used to delineate primary mammary neoplasms from extra-mammary metastasis. Yet cytological and histopathological examination remains gold standard for differentiation and diagnosis (Table 1) .
Immunohistochemistry plays a crucial role in differentiation. TTF-1 is expressed in 68-80% of lung adenocarcinomas and never reported in breast primary. ER is expressed in 80% and GCDFP-15 in 45-53% of breast carcinomas. Lung adenocarcinoma may show low ER 7.6-14.1% expression. 5.2-15% lung adenocarcinomas express GCDFP-1. Mammaglobin is expressed in 48-72.1% mammary adenocarcinomas but stains negatively in pulmonary adenocarcinoma [9] [10] [11] [12] .
Conclusion
The importance of this case is to highlight IHC as an able tool to distinguish extra-mammary metastasis that masquerade as mammary neoplasm thereby preventing unnecessary need of surgery and radiation therapy.
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